Millions of more Americans may become eligible to receive boosters after a federal advisory committee voted last week to support additional shots of the Moderna and Johnson & Johnson COVID-19 …
Millions of more Americans may become eligible to receive boosters after a federal advisory committee voted last week to support additional shots of the Moderna and Johnson & Johnson COVID-19 vaccines. Last week, the FDA’s advisory panel – called the Vaccines and Related Biological Products Advisory Committee – voted unanimously to support boosters of the Moderna vaccines for a limited population. That same committee voted unanimously to support a second dose of the Johnson & Johnson vaccine on Friday. The FDA followed suit this week by giving authorization for the other two manufacturers’ shots and adding a “mix and match” option. About 15 million adults in the U.S. have been fully vaccinated with the one-dose J&J vaccine, compared with 103 million who’ve gotten Pfizer and 69 million who’ve gotten Moderna, both of which have a two-dose regimen. So far,8.8 million Americans have received a booster dose of the Pfizer vaccine. The Biden administration said it has pre-purchased enough doses of COVID-19 vaccine to continue to provide them at no cost to Americans. Here’s who is expected to be eligible for booster doses of all three vaccines. It’s unclear if everyone will need a booster at some point in the future after recent data suggested immunity from the vaccines may be waning, but for now, not every American is eligible to get one.
